| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 81 |
| 1 | ANASTROZOLE | 8 |
| 2 | ANASTROZOLE TABLETS | 8 |
| 3 | ESCITALOPRAM | 7 |
| 4 | ESCITALOPRAM OXALATE | 7 |
| 5 | SERTRALINE | 7 |
| 6 | ESCITSLOPRAM | 6 |
| 7 | ESTRADIOL | 6 |
| 8 | LETROZOLE | 6 |
| 9 | LETROZOLE TABLETS | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FINASTERIDE | 81 | 0.0013 |
| 1 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 1 | 0.0013 |
| 2 | PRALSETINIB | 1 | 0.0005 |
| 3 | ANASTROZOLE TABLETS | 8 | 0.0004 |
| 4 | APALUTAMIDE | 3 | 0.0002 |
| 5 | SELENIUM | 1 | 0.0002 |
| 6 | ANASTROZOLE | 8 | 0.0002 |
| 7 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 2 | 0.0002 |
| 8 | CLOBETASOL PROPIONATE | 2 | 0.0002 |
| 9 | RIBOCICLIB | 6 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 81 |
| 1 | Aromatase Inhibitor [EPC] | 8 |
| 2 | Estrogen [EPC] | 6 |
| 3 | Progestin [EPC] | 5 |
| 4 | Progestin-containing Intrauterine System [EPC] | 5 |
| 5 | Androgen [EPC] | 4 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 3 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 3 |
| 8 | Androgen Receptor Inhibitor [EPC] | 2 |
| 9 | Anti-epileptic Agent [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 81 | 0.0008 |
| 1 | Photoenhancer [EPC] | 1 | 0.0003 |
| 2 | Androgen [EPC] | 4 | 0.0001 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Aromatase Inhibitor [EPC] | 8 | 0.0001 |
| 5 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 3 | 0.0000 |
| 7 | Copper-containing Intrauterine Device [EPC] | 2 | 0.0000 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Estrogen [EPC] | 6 | 0.0000 |